Europe’s Innovation Deficit: How the EU’s Business R&D Gap Fuels a Structural
Despite ambitious policy targets, the European Union has failed to close

Despite ambitious policy targets, the European Union has failed to close
Europe’s Innovation Deficit: How the EU’s Business R&D Gap Fuels a Structural Lag Behind the US and China
Introduction: The Stalling European Dream – Why GDP per Capita and Productivity Can’t Break the Two-Thirds Ceiling
For more than two decades, the European Union has chased a tantalizing but elusive goal: closing the living standards gap with the United States. Yet despite repeated policy pledges, successive strategic frameworks, and billions of euros in public investment, a stark reality persists. EU GDP per capita has remained stubbornly locked at roughly 66% of the US level since the early 2000s. The headline figure conceals an even more troubling trend: productivity growth has flatlined, and the structural drivers of long-term prosperity are weakening.
The 2024 high-level report on European competitiveness, commissioned by former Italian Prime Minister Mario Draghi, delivered a blunt warning. Europe, Draghi argued, must fundamentally refocus its innovation efforts or risk falling into a permanent second-tier position in the global economy. The report identified a crucial disconnect: the EU’s ambitions for technological sovereignty and green leadership are not matched by the scale and intensity of corporate investment in research and development.
This article argues that the EU innovation gap cannot be explained by insufficient public spending. Instead, the central bottleneck is the persistent and widening deficit in business R&D Europe – the money that companies themselves allocate to inventing new products, processes, and services. New data from Eurostat, the OECD, and national statistical agencies reveal that in 2022, EU27 business R&D as a share of GDP was just 1.41%, compared to 2.68% in the United States and 1.87% in China. That gap has widened significantly since 2015, when the EU stood at 1.31% against the US at 2.40% and China at 1.60%. The story of Europe’s structural lag is, above all, a story of corporate underinvestment.
[IMAGE: A comparative line chart showing GDP per capita ratios (EU/US) from 1990 to 2022, with a flat line around 0.66.]
The Productivity Puzzle: Total Factor Productivity Growth Trajectories and Their Root Causes
To understand why the EU’s GDP per capita ceiling persists, one must look beyond headline numbers to total factor productivity (TFP) – the measure of how efficiently an economy combines labor and capital to produce output. Europe’s TFP growth has been anaemic for decades. Data from the OECD show that EU TFP growth began to lag behind the United States in the early 1990s, when America’s tech-driven productivity boom took off. Europe briefly caught up between 2013 and 2019, driven by recovery from the eurozone crisis and modest gains in services. But the post-2020 period has been unforgiving.
Since 2020, the EU vs US vs China productivity divergence has widened sharply. The United States experienced a more vigorous private-sector recovery, powered by massive investments in digital infrastructure, artificial intelligence, cloud computing, and biotechnology. American companies – led by tech giants like Microsoft, Alphabet, Amazon, and a vibrant venture capital ecosystem – poured capital into R&D and automation, boosting productivity. Meanwhile, Europe’s recovery was more subdued. Its corporate sector, especially outside a few world-class clusters in Germany and Scandinavia, remained cautious. Digital adoption among small and medium enterprises (SMEs) lagged, and public-sector research – while strong in basic science – struggled to convert breakthroughs into commercial products.
The root cause is structural. Europe’s economy is built on a foundation of established industries: automotive, machinery, chemicals, and luxury goods. These sectors are innovation-intensive in incremental ways but have not generated the disruptive, software-driven productivity leaps seen in the US tech sector. Moreover, Europe’s TFP growth has been held back by slower reallocation of resources from low-productivity firms to high-productivity ones – a dynamic that US labor markets and financial systems handle more efficiently. The result is a productivity puzzle where Europe invests heavily in education and research but fails to realize the same aggregate returns.
[IMAGE: A dual-axis chart comparing TFP growth rates for EU and US (annual % change) with key periods highlighted (1990s, 2013–2019, 2020–2022).]
Beyond the 3% Target: Why EU R&D Intensity Lags Despite Comparable Government Funding
European policymakers have long set a target of spending 3% of GDP on R&D. The Barcelona target, established in 2002, aimed to reach that level by 2010 – a milestone that has been repeatedly missed. But a closer look at the composition of R&D spending reveals a more nuanced picture. Government-financed R&D as a share of GDP is nearly identical between the EU and the US. In 2022, the EU stood at 0.66% and the US at 0.69%, while China was lower at 0.46%. European governments are not neglecting research funding; in fact, many national systems and the EU’s Horizon Europe program provide robust support for basic science.
The real divergence lies in business enterprise R&D (BERD) – the portion of R&D performed and funded by companies. EU business-performed R&D as a share of GDP was only 52% of the US level in 2022. That ratio has narrowed from 63% in 2015, meaning Europe is not merely failing to catch up but is actively falling further behind. In absolute terms, US business R&D spending was approximately $475 billion in 2022, compared to roughly $270 billion for the EU27 – a gap of over $200 billion.
The consequences are cascading. Without strong business R&D, innovations are less commercialized. European universities produce world-class research – as measured by publication citations – but the translation into patents, startups, and market-leading products is far weaker. The corporate innovation deficit means that breakthrough technologies developed in European labs are often commercialized elsewhere. For instance, the basic research for lithium-ion batteries and genomics had strong European roots, but the scaled-up production and market dominance went to Asia and America.
Furthermore, this imbalance affects global R&D spending patterns. Multinational corporations are increasingly concentrating their high-value R&D activities in the United States and China, drawn by larger venture capital markets, deeper talent pools, and more favourable regulatory environments. The Draghi report 2024 explicitly warned that Europe’s ability to attract and retain corporate R&D centres is eroding, threatening the continent’s long-term technological sovereignty.
[IMAGE: Stacked bar chart: R&D as % GDP split by source (government, business, other) for EU, US, China in 2022 – show the large business R&D block for US vs EU.]
The Draghi Diagnosis: Structural Failures in Europe’s Corporate Innovation Ecosystem
The Draghi report did not mince words. It identified four structural reasons behind the EU’s corporate innovation failure. First, fragmented markets. Unlike the US with its single large market, European companies face 27 different regulatory regimes, tax systems, and patent enforcement frameworks. This fragmentation raises the cost of scaling up innovative products across borders. Second, risk-averse capital markets. Europe’s venture capital ecosystem is a fraction the size of America’s. European pension funds and insurance companies allocate far less capital to high-risk, high-return technology investments. The lack of a deep equity market for growth companies means many promising startups either stall or relocate to the US.
Third, insufficient linkages between research and industry. While Europe excels in public research institutions, the mechanisms for technology transfer – such as university spin-offs, joint industry labs, and innovation clusters – remain underdeveloped compared to the US model. The European innovation system has too many silos. Fourth, regulatory burden and energy costs. The Draghi report highlighted that Europe’s complex regulatory environment, especially in digital services, data governance, and chemical approvals, imposes disproportionate costs on young, innovative companies. High energy prices – a legacy of the 2022 energy crisis – further erode the competitiveness of European manufacturing R&D.
These structural factors are not new, but they are becoming more consequential as technology cycles accelerate. In the past, Europe could rely on its strengths in incremental engineering and high-quality manufacturing to remain competitive. Today, the most valuable innovations are digital, platform-based, and data-intensive – precisely the areas where Europe’s weaknesses are most acute.
The Global R&D Relocation: Where Are the Winners and Losers?
A critical dimension of the EU innovation gap is the changing geography of global R&D. While Europe’s share of global business R&D spending has been declining, China’s has surged. According to data from the OECD, China’s business R&D spending overtook that of the EU in 2019 and now exceeds it by a growing margin. The United States remains the largest single R&D performer, but its share of global BERD fell from 40% in 2000 to around 31% in 2022, partly because China’s rapid growth compressed everyone’s relative share.
Within Europe, the picture is uneven. Germany accounts for about 30% of EU business R&D, driven by its automotive and chemical sectors. But even German companies have warned of R&D relocation to Asia, where they can build factories closer to growing markets for electric vehicles and batteries. France, the Netherlands, and Sweden have pockets of strength in digital and biotech, but smaller EU member states struggle to build critical mass. The net effect is a European industrial policy landscape that is fragmented and reactive.
The global R&D spending shift has profound implications for Europe’s ability to shape future technologies. When a European company relocates its R&D centre to Shanghai or Texas, it takes not only its budget but also its supply chain relationships, its talent training programmes, and its ability to influence technical standards. This is the structural lag that the Draghi report warned about: without a reversal in the corporate R&D trend, Europe risks becoming a consumer of technologies designed and commercialised elsewhere.
Market Dynamics and the Path Forward: Rebalancing Europe's Industrial Policy
To close the gap, Europe cannot rely on public-sector spending alone. The 3% target will remain aspirational unless the business community fundamentally changes its investment calculus. The Draghi report proposed a package of measures: completing the capital markets union to unlock Europe’s €330 trillion household savings for venture investment; creating a pan-European ‘innovation fund’ to co-invest with private capital in strategic technologies; streamlining state aid rules to allow faster support for green and digital R&D; and reforming insolvency laws to reduce the stigma of failure for entrepreneurs.
The EU competitiveness agenda is now moving in this direction. The European Commission’s 2024-2029 work programme has made innovation and productivity a top priority. But real change requires political courage. Member states are reluctant to cede control over tax incentives or patent systems. And some of Europe’s largest incumbent industries, which benefit from the current fragmented structure, resist disruption.
Nevertheless, there are signs of hope. The EU’s Chips Act, while imperfect, has triggered large corporate investment in semiconductor R&D. Germany’s Hydrogen Strategy and France’s “France 2030” plan have mobilised billions in business-matched funding. And a new wave of European deep-tech startups – in areas like quantum computing, renewable energy, and AI-driven biotech – are demonstrating that world-class corporate innovation can happen in Europe, provided the ecosystem is right.
The question is whether these sparks can ignite a broader transformation. The data is clear: business R&D is the lever that determines long-run productivity. Without a structural shift in how European companies invest in the future, the two-thirds ceiling on GDP per capita will remain. The European industrial policy debate must move beyond headline spending targets to address the fundamental architecture of innovation finance, market integration, and risk culture.
[IMAGE: An analysis of R&D spending trends over time - dual axis chart showing EU business R&D as % GDP vs US & China (2000–2022) with a widening gap after 2015.]
Conclusion: The Clock Is Ticking
Europe’s innovation deficit is not an inevitable fate. It is the product of policy choices, market structures, and cultural attitudes that can be reformed. But the window for action is narrowing. The US and China are accelerating their corporate R&D investments, and the technologies shaping the next two decades – artificial intelligence, advanced manufacturing, clean energy, and biotechnology – will be dominated by those who invest most today.
The Draghi report 2024 provides a roadmap. It calls for a fundamental reorientation of European priorities: from protecting legacy industries to fostering disruptive ones; from fragmented national approaches to a genuine single market for innovation; from public-led research to business-led commercialisation. Whether Europe heeds that call will determine not just its GDP per capita ratio, but its ability to remain a global leader in the 21st century.
For now, the numbers are stark. EU business R&D at 1.41% of GDP against 2.68% in the US tells a story of persistent underinvestment. The structural lag is real, measurable, and growing. The solution lies not in spending more public money, but in creating the conditions for private capital and corporate ambition to flourish. Europe has the scientists, the universities, and the industrial base. What it lacks is the institutional framework to turn that potential into productivity. That is the challenge, and it will define the continent’s economic future.
James Morrison
James has covered European business for over 15 years, specializing in corporate strategy and cross-border M&A.